Publications by authors named "Aurelie Rabier"
Article Synopsis
- Immunotherapies like immune checkpoint inhibitors show promise in treating cancers but can cause unpredictable immune-related adverse events (irAEs) that affect patients' quality of life.
- QUALITOP is a real-world study involving around 1800 cancer patients from France, the Netherlands, Portugal, and Spain, focusing on the relationship between irAEs and health-related quality of life (HRQoL).
- The study will use advanced statistical methods and collect data through questionnaires and electronic health records over 18 months to better understand the impact of immunotherapy on patients' well-being.
Background: ICIs have dramatically improved patient outcomes in different malignancies. However, the impact of liver metastases (LM) and number of metastatic sites (MS) remains unclear in patients treated with single-agent anti-PD(L)1. Methods: We aimed to assess the prognostic impact of LM and MS number on progression-free survival (PFS) and overall survival (OS) in a large single-arm retrospective multicentric cohort (IMMUCARE) of patients treated with anti-PD(L)-1 for different solid tumors.
View Article and Find Full Text PDF